These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23982344)

  • 21. Effects of gold complexes on the assembly behavior of human islet amyloid polypeptide.
    He L; Zhu D; Zhao C; Jia X; Wang X; Du W
    J Inorg Biochem; 2015 Nov; 152():114-22. PubMed ID: 26383119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
    Kawahara M; Koyama H; Nagata T; Sadakane Y
    Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methionine oxidation of amyloid peptides by peroxovanadium complexes: inhibition of fibril formation through a distinct mechanism.
    He L; Wang X; Zhu D; Zhao C; Du W
    Metallomics; 2015 Dec; 7(12):1562-72. PubMed ID: 26444976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hetero-oligomeric Amyloid Assembly and Mechanism: Prion Fragment PrP(106-126) Catalyzes the Islet Amyloid Polypeptide β-Hairpin.
    Ilitchev AI; Giammona MJ; Olivas C; Claud SL; Lazar Cantrell KL; Wu C; Buratto SK; Bowers MT
    J Am Chem Soc; 2018 Aug; 140(30):9685-9695. PubMed ID: 29989407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PrP106-126 peptide disrupts lipid membranes: influence of C-terminal amidation.
    Zheng W; Wang L; Hong Y; Sha Y
    Biochem Biophys Res Commun; 2009 Feb; 379(2):298-303. PubMed ID: 19103159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulating the aggregation of human prion protein PrP
    Chauhan R; Navale GR; Saini S; Panwar A; Kukreti P; Saini R; Roy P; Ghosh K
    Dalton Trans; 2024 Jul; 53(28):11995-12006. PubMed ID: 38963284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interaction of TPPP with PrP antagonized the CytoPrP-induced disruption of microtubule structures and cytotoxicity.
    Zhou RM; Jing YY; Guo Y; Gao C; Zhang BY; Chen C; Shi Q; Tian C; Wang ZY; Gong HS; Han J; Xu BL; Dong XP
    PLoS One; 2011; 6(8):e23079. PubMed ID: 21857997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calnexin inhibits thermal aggregation and neurotoxicity of prion protein.
    Wang W; Chen R; Luo K; Wu D; Huang L; Huang T; Xiao G
    J Cell Biochem; 2010 Oct; 111(2):343-9. PubMed ID: 20506117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
    Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
    J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of the human prion protein PrP106-126 with metal complexes: potential therapeutic agents against prion disease.
    Wang Y; Xu J; Wang L; Zhang B; Du W
    Chemistry; 2010 Dec; 16(45):13339-42. PubMed ID: 21031373
    [No Abstract]   [Full Text] [Related]  

  • 31. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
    Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
    J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific binding modes of Cu(I) and Ag(I) with neurotoxic domain of the human prion protein.
    Valensin D; Padula EM; Hecel A; Luczkowski M; Kozlowski H
    J Inorg Biochem; 2016 Feb; 155():26-35. PubMed ID: 26606290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectroscopic and electronic structure studies of copper(II) binding to His111 in the human prion protein fragment 106-115: evaluating the role of protons and methionine residues.
    Rivillas-Acevedo L; Grande-Aztatzi R; Lomelí I; García JE; Barrios E; Teloxa S; Vela A; Quintanar L
    Inorg Chem; 2011 Mar; 50(5):1956-72. PubMed ID: 21261254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.
    Ning L; Pan D; Zhang Y; Wang S; Liu H; Yao X
    PLoS One; 2015; 10(5):e0125899. PubMed ID: 25993001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymerization of human prion peptide HuPrP 106-126 to amyloid in nucleic acid solution.
    Nandi PK
    Arch Virol; 1998; 143(7):1251-63. PubMed ID: 9722872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic.
    Florio T; Paludi D; Villa V; Principe DR; Corsaro A; Millo E; Damonte G; D'Arrigo C; Russo C; Schettini G; Aceto A
    J Neurochem; 2003 Apr; 85(1):62-72. PubMed ID: 12641727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between 14-3-3β and PrP influences the dimerization of 14-3-3 and fibrillization of PrP106-126.
    Han J; Song QQ; Sun P; Zhang J; Wang X; Song J; Li GQ; Liu YH; Mei GY; Shi Q; Tian C; Chen C; Gao C; Zhao B; Dong XP
    Int J Biochem Cell Biol; 2014 Feb; 47():20-8. PubMed ID: 24269782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic miniprion PrP106.
    Bonetto V; Massignan T; Chiesa R; Morbin M; Mazzoleni G; Diomede L; Angeretti N; Colombo L; Forloni G; Tagliavini F; Salmona M
    J Biol Chem; 2002 Aug; 277(35):31327-34. PubMed ID: 12058037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.
    Brown DR
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):785-91. PubMed ID: 10698707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.